Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...

For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...

The Depo-Provera birth control shot has been linked to an increased risk of a type of brain tumors known as meningiomas. Women who received the Depo shot and were diagnosed with meningioma brain ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has approved a label change to Pfizer's contraceptive injection The US Food and Drug Administration (FDA) has approved a ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...

Recent research has linked Pfizer’s widely-used Depo-Provera birth control shot to massively increased risk of developing brain tumors — and hundreds of women are suing the pharmaceutical giant over ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

More Australian women have come forward with concerns about serious side effects from the popular contraceptive Depo-Provera, with many claiming they were not made aware of the risks of the high-dose ...

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low UK law firms are considering legal action on behalf of women who developed ...